Search results
FDA Advisers Urge Targeting JN.1 Strain in Recipe for Fall's COVID Vaccines
US News & World Report· 1 day agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall -- targeting a version of ...
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
InvestorPlace· 13 hours agoVaccine maker Novavax (NASDAQ:NVAX) saw its shares jump 18% on June 5 and another 20% in pre-market...
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say
Reuters· 2 days agoCOVID-19 vaccine makers said data from animals studies showed their 2024-25 shots targeting the JN.1...
FDA advisers urge targeting JN.1 strain for fall’s COVID vaccines
Marshall Independent· 19 hours agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall — targeting a version of ...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
Stamford Advocate· 1 day agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
Novavax's stock surges almost 300% in the past month
AOL· 9 hours agoNovavax stock (NVAX) is on a tear — soaring nearly 300% in the past month to $19.56 per share — following several pieces of good news. The Food and Drug Administration (FDA) today finally set ...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
U-T San Diego· 1 day agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall -- targeting a version of ...
FDA Advisers Recommend Omicron-Focused COVID Boosters for Fall
Homenewshere.com· 8 hours agoFDA advisers recommended that the new COVID-19 boosters for fall target the Omicron variant, which...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer | The Motley...
The Motley Fool· 3 days agoPfizer (PFE 0.61%) investors have been through a lot of ups and downs over the past few years....
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 7 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
